Thursday, February 2, 2023
No Result
View All Result
  • Home
  • Recent
  • Business
  • Economy
  • Investing
  • Markets
  • Personal Finance
  • Retirement
  • Tech
  • Startups
  • Insurance
  • Market Research
  • Crypto
  • Home
  • Recent
  • Business
  • Economy
  • Investing
  • Markets
  • Personal Finance
  • Retirement
  • Tech
  • Startups
  • Insurance
  • Market Research
  • Crypto
No Result
View All Result
Home Markets

Top Biotechnology Stocks in India

Updates Finance by Updates Finance
July 14, 2022
in Markets
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Top Biotechnology stocks in India: Technology has evolved rapidly over the last few decades. This has revolutionized the way we live in our day-to-day lives. This has given rise to multiple new fields in commercial science. One of those fields is Biotechnology.

It is one of the evolving fields which combines both science and technology. In this article, we will take a look at the top biotechnology stocks in India. Keep reading to find out!

Industry Overview

India is amongst the top 12 destinations for biotechnology in the world. The industry comprises around 5000 biotech companies, with 4,240 being start-ups out of which 760 are core biotech companies.

India is also one of the first countries to have a department dedicated to the Biotechnology industry. The industry has huge growth potential as many resources still remain untapped.

One of the main growth drivers of the company has been government support. The Union Budget 2022-23 US$343.56 million was allocated for developing basic infrastructure, genetic engineering, bioinformatics, agriculture biotechnology, and training people.

SK_espresso_OBrokerageOnLoss_V5_1500x1500

As of 2021, India’s biotech industry clocks in about US$12 billion in annual revenue. In fact, the industry is expected to reach US$150 billion by 2025, with a CAGR of 16.4%.

Top Biotechnology stocks in India

Let us have a detailed look at the top stocks in the Biotechnology industry.

Biotechnology stock in India #1 – Biocon Ltd

Face Value (₹): 5 ROE (%): 13.16
Market Cap (Cr): ₹39,248Cr Net Profit Margin: 13.02
EPS (TTM) (₹): 5 Debt to Equity: 0.58
Stock P/E (TTM): 60.53 Current Ratio 1.81
Dividend Yield (%): 0.15 Promoter’s Holdings (%): 60.64

Biocon Ltd. is an Indian biotechnological company. Founded by Kiran Mazumdar-Shaw in 1978, Biocon mainly manufactures generic active pharmaceutical ingredients (APIs). The products of the company are sold in more than 120 countries. 

It is the only company to get FDA approval for 3 biosimilar molecules (Trastuzumab, Pegfilgrastim and Insulin Glargine). It also produces & markets a mix of speciality & industrial enzymes for industries like paper, brewing, beverages, food, brewing, textiles & distilling.

The financials of the large-cap stock looks strong as it has earned a revenue of Rs. 7,105.80 Cr in FY21 while it has a net profit of Rs. 740.50 Cr. However, the cash flow position has been declining in the last few quarters. On the brighter side, the company has high promoters holding and zero promoters pledge.

Biotechnology stock in India #2 – SPARC

Face Value (₹): 1 ROE (%): 0
Market Cap (Cr): ₹5,527Cr Net Profit Margin: -59.75
EPS (TTM) (₹): -7 Debt to Equity: -1.4
Stock P/E (TTM): 0 Current Ratio 0.27
Dividend Yield (%): 0 Promoter’s Holdings (%): 69.09

Sun Pharma Advanced Research Company (SPARC) is a clinical-stage biopharmaceutical company. The company was incorporated in 2007 after it was demerged from Sun Pharmaceutical Industries Ltd.

The company has developed 2 USFDA-approved drugs so far. The company is focused on innovating drug delivery technologies required for the treatment of cancers and psychiatric ailments.

The small-cap company reported net sales of Rs. 252.96 Cr in FY21. Apart from that, it reported a net loss of Rs. 151.14 Cr. in the same period. The cash flow position of the company also seems to be improving over the last few quarters. The company has a promoter’s pledge of 2.18% as of March 2022.

Biotechnology stock in India #3 – Windlas Biotech

Face Value (₹): 5 ROE (%): 7.7
Market Cap (Cr): ₹479Cr Net Profit Margin: 7.2
EPS (TTM) (₹): 17 Debt to Equity: 0.16
Stock P/E (TTM): 12.51 Current Ratio 2.08
Dividend Yield (%): 1.59 Promoter’s Holdings (%): 59.95

Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Established in 2001, It manufactures both solid and liquid pharmaceutical dosage forms.

Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations and CDMO industry in India in terms of revenues. Apart from that, the company provides CDMO services to 7 of the top 10 Indian formulations pharmaceutical companies. 

In FY21, the company reported a revenue of Rs. 427.60 Cr. and a net profit of Rs. 15.83 Cr. In addition to that, the biotechnology company has been able to increase its cash flow position over the last few quarters. It has low debt and Zero Promoters Pledge in its financials.

List of all Biotechnology stocks in India

Stock Market Cap (Rs in Crores)
Biocon 38,377.18
Sun Pharma Advanced Research Company Ltd. 5,656.44
Windlas Biotech Ltd. 484.92
ANG Lifesciences India Ltd. 208.27
Vivo Biotech Ltd. 47.98
Syngene International Ltd 22,811
Supriya Lifescience Ltd 2,677

In closing

In this article, we looked at the top stocks that are operating in the Biotechnology industry in India. We also looked at the overall industry and its performance. The Biotech industry is still a growing sector in India and has a huge potential to grow in the years to come.

This brings an opportunity for businesses and investors to tap into the market. That’s all for this article on Top Biotechnology stocks in India. Happy Investing! 

You can now get the latest updates in the stock market on Trade Brains News and you can even use our Trade Brains Portal for fundamental analysis of your favourite stocks.

tradebrains portal app download



Source link

You might also like

Mark Zuckerberg’s Meta has best day in a decade as it adds over $100 billion in value.

adani-hindenburg row: Ratings on all Adani Group entities under ‘continuous surveillance’: CRISIL

Peltz’s Trian seeks to rally Disney shareholders against board director Froman By Reuters

Tags: BiotechnologyIndiastocksTop
Share30Tweet19
Updates Finance

Updates Finance

Recommended For You

Mark Zuckerberg’s Meta has best day in a decade as it adds over $100 billion in value.

by Updates Finance
February 2, 2023
0

This stock was clearly criminally underrated when it went under $100 per share in 2022. We'll have to see it if it gets back to its all time...

Read more

adani-hindenburg row: Ratings on all Adani Group entities under ‘continuous surveillance’: CRISIL

by Updates Finance
February 2, 2023
0

Taking note of the massive report issued by US-based whistleblower Hindenburg Research on the Adani Group and the consequent crash in stock prices, Ratings said that it is...

Read more

Peltz’s Trian seeks to rally Disney shareholders against board director Froman By Reuters

by Updates Finance
February 2, 2023
0

2/2 © Reuters. FILE PHOTO: The signage at the main gate of The Walt Disney Co. is pictured in Burbank, California, May 7, 2012. Picture taken May 7,...

Read more

Renishaw plc (RNSHF) Q2 2023 Earnings Call Transcript

by Updates Finance
February 2, 2023
0

Renishaw plc (OTCPK:RNSHF) Q2 2023 Earnings Conference Call February 2, 2023 5:30 AM ET Company Participants Chris Pockett - Head of Communications Will Lee - Chief Executive Allen...

Read more

Fundamental Analysis of Axis Bank

by Updates Finance
February 2, 2023
0

Fundamental Analysis of Axis Bank: Banks occupy a substantial portion of the overall stock market and they find their way into the portfolios of many investors. This can...

Read more
Next Post

How to Create Key Partnerships as a Startup

Related News

Portfolio in the red? How tax-loss harvesting can help stem the pain

June 17, 2022

Survey Reveals Top Takeaways of 2022 Holiday Retail

January 13, 2023

5 Definitive Ways to Drive a High-Growth Business

January 19, 2023

Browse by Category

  • Business
  • Cryptocurrency
  • Economy
  • Insurance
  • Investing
  • Latest updates
  • Market Research
  • Markets
  • Personal Finance
  • Retirement
  • Startups
  • Technology

Get the latest Financial news on updatesfinance.com. Business news, Economy news, Investing news, Personal Finance and more.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Insurance
  • Investing
  • Latest updates
  • Market Research
  • Markets
  • Personal Finance
  • Retirement
  • Startups
  • Technology

Recent News

  • This Is Where Subway’s Co-Founder Left Half of His Fortune
  • Ascendant Resources Announces High Grade Copper Assay Results Supporting High-Grade Copper Corridor at the Venda Nova South Zone

Copyright © 2022 - Updates Finance..

No Result
View All Result
  • Home
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Updates Finance..

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?